VERTEX PHARMACEUTICALS INC / MA cotiza a 510.08 USD y tiene una capitalización bursátil de $129.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta t…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $4.73 | $4.47 | $5.03 |
| Estimado | $-0.74 | $4.75 | $4.31 | $5.15 |
| Sorpresa | — | -0.4% | +3.7% | -2.3% |
| Métrica | VRTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 86.2% | 57.0% | +29.2% |
| Operating Margin | 34.8% | -38.6% | +73.4% |
| Net Margin | 32.9% | -33.6% | +66.5% |
| FCF Margin | 26.6% | -13.9% | +40.5% |
| ROE | 21.2% | -40.4% | +61.6% |
| ROA | 15.4% | -32.0% | +47.4% |
| Current Ratio | 2.90 | 2.84 | +0.06 |
| Debt / Equity | — | 0.28 | — |